Sex-specific alterations in placental mitochondria, oxidative damage and apoptosis in mice of advanced maternal age
Reproduction · 16.08.2025 · 170 (4)
DOI: 10.1530/rep-25-0160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, erschienen am 16.08.2025. Verfasst von Jessica Dalton-O'Reilly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Oxidative Stress, Mitochondria, Placenta, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
In brief Advanced maternal age (AMA) is associated with adverse pregnancy outcomes, particularly those associated with placental dysfunction. This study showed that in a mouse model of AMA, male but not female fetuses had increased placental apoptosis and lipid peroxidation, as well as increased mitochondrial content, suggesting that the placentas of male fetuses in AMA mothers adapt to be able to deliver sufficient energy to the fetus. Abstract Although advanced maternal age (AMA) increases the risk of fetal growth restriction (FGR) and stillbirth, the mechanisms leading to the placental dysfunction observed in AMA are unknown. Mitochondrial function declines and oxidative stress increases with age. Furthermore, FGR, of which placental dysfunction is a major cause, is associated with alterations in respiratory function of placental mitochondria. Therefore, this study aimed to examine placental mitochondrial function, oxidative stress, and apoptosis in AMA mice using respirometry and immunohistochemistry. Relative to young mice (12–16 weeks), AMA mice (36–42 weeks) demonstrated reduced weight in both female and male fetuses, but placental alterations occurred in a sex-specific manner. In AMA, lipid peroxidation and apoptosis were increased in the placental junctional zone (Jz) and labyrinth zone (Lz) of male but not female fetuses. Placental mitochondrial content was significantly increased in the Lz and Jz of male fetuses and the Lz of female fetuses in AMA. When normalised to sample mitochondrial content, complex I + II-linked respiration, electron transfer capacity, and complex IV activity were significantly reduced in the Jz of male fetuses and Lz of female fetuses in AMA. However, when normalised to protein content, no differences were observed in placentas of female fetuses; in the Lz of male fetuses, complex I-linked respiration was increased and complex IV activity was reduced. Collectively, these findings suggest that the observed increase in mitochondrial content could be an adaptation by the placenta to maintain appropriate bioenergetic capacity and that oxidative damage may contribute to placental dysfunction in male fetuses in AMA pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom.
- Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Saint Mary's Hospital, Manchester, United Kingdom.
ORCID-Profile: Jessica Dalton-O'Reilly
Zitieren
APA
Dalton-O'Reilly, J., Heazell, A. E. P., Greenwood, S., Dilworth, M., & Desforges, M. (2025). Sex-specific alterations in placental mitochondria, oxidative damage and apoptosis in mice of advanced maternal age. Reproduction, 170(4). https://doi.org/10.1530/rep-25-0160
Vancouver
Dalton-O'Reilly J, Heazell AEP, Greenwood S, Dilworth M, Desforges M. Sex-specific alterations in placental mitochondria, oxidative damage and apoptosis in mice of advanced maternal age. Reproduction. 2025;170(4). doi:10.1530/rep-25-0160
BibTeX
@article{DaltonOReilly2025,
author = {Dalton-O'Reilly, Jessica and Heazell, Alexander E P and Greenwood, Susan and Dilworth, Mark and Desforges, Michelle},
title = {Sex-specific alterations in placental mitochondria, oxidative damage and apoptosis in mice of advanced maternal age},
journal = {Reproduction},
year = {2025},
volume = {170},
number = {4},
doi = {10.1530/rep-25-0160}
}
EUVIMED